Finance

Beta
Ask
Lists
NXTC:NASDAQ
NextCure Inc
$2.02
-8.18%
(-0.18) 1D
$2.12
+4.95% (+0.100)
After hours
Closed: Jun 18, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NXTC...
Open
$2.20
High
$2.25
Low
$2.00
Mkt. cap
7.30M
Avg. vol.
115.51K
Volume
59.03K
52-wk high
$15.74
52-wk low
$1.78
EPS
-$18.75
Beta
1.30
Shares outstanding
3.61M
No. of employees
40
Open
$2.20
High
$2.25
Low
$2.00
Mkt. cap
7.30M
Avg. vol.
115.51K
Volume
59.03K
52-wk high
$15.74
52-wk low
$1.78
EPS
-$18.75
Beta
1.30
Shares outstanding
3.61M
No. of employees
40
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to NXTC in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for NXTC in the last 3 months.
Highest
Current $2.02
$25.00 (+1,137.62%)
Average
$20.00 (+890.10%)
Lowest
$15.00 (+642.57%)
News stories
From sources across the web
About NextCure Inc
CEO-
Employees40
Founded2015
Headquarters-
SectorBiotechnology
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$1.87 / -$1.84
-1.36%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
24.09M
6.14M
6.80M
6.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.20M
2.81M
2.96M
3.27M
Operating expense
27.29M
8.94M
9.76M
10.10M
Total operating expenses
27.29M
8.94M
9.76M
10.10M
Operating income
-27.29M
-8.94M
-9.76M
-10.10M
Other non operating income
-
-
-
-
EBT including unusual items
-26.81M
-8.62M
-9.44M
-9.80M
EBT excluding unusual items
-26.81M
-8.62M
-9.44M
-9.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-26.81M
-8.62M
-9.44M
-9.80M
Net profit margin
-
-
-
-
Earnings per share
-11.29
-3.22
-0.81
-1.87
Interest and investment income
484.00K
321.00K
321.00K
309.00K
Interest expense
-
-
-
-
Net interest expenses
484.00K
321.00K
321.00K
309.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.66M
-8.41M
-9.39M
-9.82M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more